0001640334-19-000761.txt : 20190507
0001640334-19-000761.hdr.sgml : 20190507
20190507160826
ACCESSION NUMBER: 0001640334-19-000761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190506
FILED AS OF DATE: 20190507
DATE AS OF CHANGE: 20190507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moss David J
CENTRAL INDEX KEY: 0001421930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 19803160
MAIL ADDRESS:
STREET 1: C/O PEGASI ENERGY RESOURCES CORPORATION
STREET 2: 218 N. BROADWAY, SUITE 204
CITY: TYLER
STATE: TX
ZIP: 75702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1224 PROSPECT STREET
STREET 2: SUITE 150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1224 PROSPECT STREET
STREET 2: SUITE 150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
form4.xml
FORM 4
X0306
4
2019-05-06-06:00
false
0001711754
Inmune Bio, Inc.
INMB
0001421930
Moss David J
C/O INMUNE BIO INC.
1224 PROSPECT STREET, SUITE 150
LA JOLLA
CA
92037
false
true
true
false
CFO, Treasurer & Secretary
Common Stock
2019-05-06-06:00
4
P
false
5000
9
A
1210417
D
Includes 5,000 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement consummated as of May 6, 2019.
/s/ David Moss
2019-05-07-06:00